Mefoglipitin Duo Tablets 2.5/1000 mg
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
MFDS item code 201908077 · Approved 2019.11.25
This product's status changed to Expired on 2024.11.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help adults with type 2 diabetes control their blood sugar levels. It can be administered either in conjunction with diet and exercise or alone, and is effective for those who have not previously received diabetes medication or who have difficulty achieving sufficient blood sugar control with metformin monotherapy. Additionally, it can be administered in place of the combination therapy of linagliptin and metformin, or when blood sugar control is inadequate with the combination of metformin and sulfonylureas, insulin and metformin, or metformin and empagliflozin. This medication aids in improving blood sugar levels in conjunction with various treatment methods.
The dose of this medicine should be determined for each patient based on the current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each ingredient: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine should be administered twice daily with meals. To reduce gastrointestinal adverse effects associated with metformin use, the dose should be increased gradually. 1. Patients not currently receiving metformin: For patients who have not previously received drug therapy for diabetes and whose blood glucose cannot be adequately controlled with monotherapy, the initial dose is 1 tablet of this medicine 2.5/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 2.5/1000 mg twice daily. 2. Patients whose blood glucose cannot be adequately controlled with metformin monotherapy: The initial dose of this medicine should provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and the patient's existing metformin dose (e.g., a patient taking metformin 1000 mg twice daily should take linagliptin 2.5 mg/metformin 1000 mg twice daily with meals). 3. Switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this medicine should start at their existing doses of linagliptin and metformin. 4. Patients whose blood glucose cannot be adequately controlled with combination therapy of metformin and a sulfonylurea: The initial dose of this medicine should provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's existing metformin dose. When this medicine is coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. 5. Patients whose blood glucose cannot be adequately controlled with combination therapy of insulin and metformin: The initial dose of this medicine should provide linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's existing metformin dose. When this medicine is coadministered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate [eGFR] 45≤~<60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Treatment should not be initiated with this medicine, since the starting dose of metformin is 500mg or 850mg once daily. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately.
This medication is used in the treatment of diabetes and helps control blood sugar levels. It should not be used in certain patients. For example, individuals who are allergic to this medication or its components, patients with type 1 diabetes, those with severe kidney impairment, patients with acute infections or dehydration, individuals with severely impaired liver function, and women who are pregnant or breastfeeding may be at risk if they take this medication. While taking this medication, one must be cautious of symptoms of hypoglycemia. Especially when taken together with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently, and medication dosages adjusted as necessary. Rare side effects such as lactic acidosis may occur, particularly in cases where kidney function declines rapidly or in the presence of heart disease, liver disease, or severe infections. Therefore, kidney function and overall health status should be regularly monitored, and symptoms should be reported to healthcare professionals immediately. Since this medication is excreted through the kidneys, elderly individuals or those with kidney disease must take extra caution and should undergo regular kidney function tests. Additionally, this medication may interact with some other drugs, so if there are other medications being taken, it is essential to inform the doctor or pharmacist, and dosage adjustment or monitoring may be required. In case of pregnancy or if planning to become pregnant, insulin therapy is recommended in place of this medication, and it is advisable not to use this medication during breastfeeding. It is not recommended for children and adolescents since its safety and efficacy have not been established. If severe abdominal pain, persistent vomiting, muscle weakness, or difficulty breathing occurs while taking this medication, consult a healthcare professional immediately. When storing this medication, keep it out of the reach of children, avoid moisture, and do not transfer it to another container.
Lactic acidosis, nasopharyngitis, hypersensitivity, angioedema, urticaria, decreased and deficient vitamin B12, hypoglycemia, taste disorder, cough, decreased appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rash, vesicular pemphigoid, severe and disabling arthralgia, rhabdomyolysis, increased lipase, increased amylase, constipation, upper abdominal pain, enterocolitis, bowel obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anxiety, depression, bruise, bone bruise, concussion, bone fracture, hand fracture, laceration, palpitations, dry eyes, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, fatty liver, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, hearing loss, erectile dysfunction, goiter, anemia, dizziness, sensory loss, asthenia, chest discomfort, nosebleed, oropharyngeal pain, voice disorder, epistaxis, vocal cord polyp, dyslipidemia, hypercholesterolemia, male-pattern baldness, hyperhidrosis, hair loss, dermatitis, insomnia, delirium, nocturia, pruritus, hypertension, benign prostatic hyperplasia, angina, acute myocardial infarction, unstable angina, diarrhea, pancreatitis, stomatitis, mediastinitis, pneumonia, rhinitis, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp, dyspepsia, rectal bleeding, cheilitis, dental caries, enteritis, gastritis, stomatitis, headache, drowsiness, osteoarthritis, limb pain, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in the blood, decreased hemoglobin, increased potassium in the blood, increased creatinine in the blood, increased creatine phosphokinase in the blood, anxiety, depression
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is also important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.
Bright pink, biconvex, oval-shaped film-coated tablets
60 tablets/PTP [(10 tablets/PTP × 6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.